Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Technical recommendations on u/s due in France

This article was originally published in Clinica

Executive Summary

With the French government having committed itself to a doubling in the fees that practitioners can charge per antenatal procedure, it is now focusing on the need to improve the quality of the images taken. The supreme health authority (HAS) is to draft recommendations, focusing on the definition and the content of the images, on initial and long-term training of doctors and midwives, and on summarising their findings and informing families. Fees were increased by 36% on March 31, and further negotiations are expected to result in a target level of Euro223 ($274), Clinica understands.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel